Therefore, we performed a meta-analysis to evaluate whether BRCA1 gene promoter methylation is a risk factor for sporadic breast cancers, and elucidated the association of BRCA1 promoter methylation with clinicopathological characteristics in patients with breast cancer. Here, BRCA1 is linked to breast carcinoma.